The VIP regimen effective treatment to refractory choriocarcinoma: a case report

Zhonghua Yi Xue Za Zhi (Taipei). 1997 May;59(5):320-4.

Abstract

This is a case report of a female patient who tried another regimen after EMA-CO regimen failed. A 30-year-old female, gravida 4, para 2, abortus 2, blood grouping O (grouping B of her husband), was a victim of choriocarcinoma of the uterus and was resistant to multiple combination regimens of chemotherapy (EMA-CO, EMA-PE, BEP). She was finally cured by the VIP regimen of chemotherapy. The VIP regimen may be considered as an effective protocol to cure refractory choriocarcinoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Choriocarcinoma / drug therapy*
  • Cisplatin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Ifosfamide / administration & dosage
  • Pregnancy
  • Uterine Neoplasms / drug therapy*

Substances

  • Etoposide
  • Cisplatin
  • Ifosfamide

Supplementary concepts

  • ICE protocol 1